Human fibrinogen (Boya Bio-Pharmaceutical)

人纤维蛋白原（博雅生物）

Report date: 2022/03/09 14:50:42

Base Information

Drug NameHuman fibrinogen (Boya Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsAfibrinogenemia
Global Approved IndicationsAfibrinogenemia
Approved Indications in ChinaAfibrinogenemia
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAfibrinogenemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A